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Environmental influences and insults by reproductive toxicant exposure can lead to impaired spermatogenesis or infertility.
Understanding how toxicants disrupt spermatogenesis is critical for determining how environmental factors contribute to
impaired fertility. While current animal models are available, understanding of the reproductive toxic effects on human
fertility requires a more robust model system. We recently demonstrated that human pluripotent stem cells can differentiate
into spermatogonial stem cells/spermatogonia, primary and secondary spermatocytes, and haploid spermatids; a model that
mimics many aspects of human spermatogenesis. Here, using this model system, we examine the effects of 2-bromopropane
(2-BP) and 1,2,dibromo-3-chloropropane (DBCP) on in vitro human spermatogenesis. 2-BP and DBCP are non-endocrine
disrupting toxicants that are known to impact male fertility. We show that acute treatment with either 2-BP or DBCP induces a
reduction in germ cell viability through apoptosis. 2-BP and DBCP affect viability of different cell populations as 2-BP primarily
reduces spermatocyte viability, whereas DBCP exerts a much greater effect on spermatogonia. Acute treatment with 2-BP or
DBCP also reduces the percentage of haploid spermatids. Both 2-BP and DBCP induce reactive oxygen species (ROS) formation
leading to an oxidized cellular environment. Taken together, these results suggest that acute exposure with 2-BP or DBCP
causes human germ cell death in vitro by inducing ROS formation. This system represents a unique platform for assessing
human reproductive toxicity potential of various environmental toxicants in a rapid, efficient, and unbiased format.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
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348 C.A. Easley IV et al.Introduction and Berndtson, 1986; Bjorge et al., 1995; Holme et al., 1991;To date, most of the pioneering work in understanding the
effects of environmental toxicants on male reproduction in
pubertal and post-pubertal exposures has been done in mice
and rats (for review, Campion et al., 2012). These rodent
models, while very informative, possess challenges and
limitations (for review, Campion et al., 2012) and typically
focus on morphological/structural defects using histopatho-
logical studies to assess exposure-related damage. Because
of the limitations of these models, sub-cellular effects of
toxicant exposure are only now just being studied and are
difficult to assess in the testis in vivo. Furthermore, these
animal studies are laborious, time consuming, and expensive
and may not replicate what happens in humans as rodent
spermatogenesis is distinctly different from human sper-
matogenesis, with rodents possessing several spermatogoni-
al amplifying events that humans do not have (Ehmcke et
al., 2006). As such, human studies on the effects of toxicant
exposure are largely relegated to clinical and epidemiolog-
ical studies examining testis tissue defects or sperm quality.
Thus, for the case of human spermatogenesis, the underlying
mechanisms by which environmental toxicants impair sper-
matogenesis are understudied and mainly extrapolated from
work in rodents.
In 1996, the US Food Quality Protection Act ordered the
EPA to implement a reproductive toxicant screening pro-
gram to begin assessing the reproductive toxic potential for
the large number of chemicals humans encounter (Tomerlin,
2000). The purpose of this Act was risk assessment for
chemicals that potentially could contribute to human
infertility (Tomerlin, 2000). To date, current models have
been burdened by a lack of sensitivity leading to inconsistent
or non-responses to toxicant exposures, which in turn
confound outcomes and lead to several false negative
results. Human pluripotent stem cells (hPSCs), including
human embryonic stem cells (hESCs), represent a unique
system by which investigators can examine the effects of
toxicants as these cells can be differentiated into any cell
type in the adult organism, including germ cells (Bucay et
al., 2009; Easley et al., 2012; Eguizabal et al., 2011;
Fukunaga et al., 2010; Geijsen et al., 2004; Kee et al.,
2009; Panula et al., 2011; Park et al., 2009; Teramura et al.,
2007; Tilgner et al., 2008; Yamauchi et al., 2009; West et
al., 2011). Recently, we demonstrated that male human
embryonic stem cells (hESCs) and induced pluripotent stem
cells (hiPSCs) are directly differentiated into adult-type
spermatogonial stem cells/spermatogonia, pre-meiotic and
post-meiotic spermatocytes, and post-meiotic spermatids
(Easley et al., 2012). Our work demonstrates the utility of
hPSCs to be used to model several key aspects of human
spermatogenesis in vitro and maintain critical windows of
susceptibility necessary to evaluate the effects of reproduc-
tive toxicants on spermatogenic cell lineages. Likewise, this
in vitro model system would permit determinations of
sub-cellular mechanisms by which reproductive toxicants
negatively impact human spermatogenesis and would allow
investigators to examine whether mechanisms observed in
rodents apply to human spermatogenic defects in a high
throughput/high content approach.
1,2-Dibromo-3-chloropropane (DBCP) is a banned nema-
ticide that has been shown to cause male infertility (AmannPotashnik and Porath, 1995; Slutsky et al., 1999; Whorton et
al., 1979). In exposed workers, DBCP is gonadotoxic resulting
in a loss of germ cells, including spermatogonia, causing
oligo- or azoospermia, without affecting the somatic Leydig
and Sertoli cells (Amann and Berndtson, 1986; Bjorge et al.,
1995; Holme et al., 1991; Potashnik and Porath, 1995;
Slutsky et al., 1999; Whorton et al., 1979). Clinical studies
also indicate that DBCP interferes with meiosis as exposed
male workers with observed sperm counts frequently gen-
erate aneuploid sperm (Kapp et al., 1979). Rodent studies
on DBCP have been erratic as some models have shown
gonadotoxicity, but others have not. Specifically, rats dem-
onstrate less tolerance and higher lethality to lower doses
of DBCP compared to their mouse counterparts (Teramoto
et al., 1980). Mouse models have indicated that DBCP does
not induce spermatogonia cell death but instead blocks
differentiation (Meistrich et al., 2003), a phenotype that
to date has not been observed in human exposure cases.
Likewise, mouse models indicate that Leydig cell loss plays a
major role in DBCP-mediated infertility (Kelce et al., 1990).
Thus, a model that mimics human exposure phenotypes is
needed to fully investigate the effects of DBCP on human
spermatogenesis.
2-Bromopropane (2-BP) was an alternative to ozone-
depleting cleaning solvents and is also used in organic synthesis
to add isopropyl groups to compounds (Anon, 2003). Recently,
the National Toxicology Program (NTP) concluded that
there was sufficient evidence to suggest that 2-BP nega-
tively impacts fertility in exposed males (Boekelheide et
al., 2004). Occupational exposure to high levels of 2-BP has
resulted in oligo- or azoospermia, and observations from
clinical samples suggest that 2-BP reduces the number of
pre-meiotic spermatocytes by affecting viability of both
spermatogonia and spermatocytes by inducing germ cell
apoptosis (Ichihara et al., 1999; Kim et al., 1996, 1999; Son
et al., 1999; Wu et al., 1999; Yu et al., 1997). The effects of
2-BP exposure in humans appear to be on germ cell viability
and not on somatic Leydig and Sertoli cell function or
viability. Studies using mouse models indicated that 2-BP
exposure in mice, like humans, shows a loss of spermatogo-
nia and spermatocytes; but some studies implicate Leydig
cell defects as the main factor behind 2-BP-mediated germ
cell death in mice. This does not appear to be the case in
humans. Even in the case of 2-BP, where rodent models
mostly mimic human exposure phenotypes, a new model
that simulates many aspects of human spermatogenesis
would be of importance to examining the exact mechanism of
how 2-BP interferes with human spermatogenesis, especially
given that 2-BP is still used.
Here, we demonstrate that we can adapt our recently
described human spermatogenic differentiation model to
examine the effects of 2-BP and DBCP on in vitro human
spermatogenesis. We demonstrate that our model mimics
phenotypes observed in human exposure cases and that both
2-BP and DBCP directly affect germ cell viability in culture.
Furthermore, we are able to utilize this system to examine
one potential cellular mechanism by which 2-BP and DBCP
affect germ cell survival. The work presented here also
validates our model system as an appropriate platform for
evaluating other environmental toxicants on human sper-
matogenic toxicity.
349In vitro model of male reproductive toxicityMaterials and methods
Human embryonic stem cell culture and
differentiation
NIH-approved WA01 (H1, WiCell, Madison, WI) male human
embryonic stem cells were cultured and maintained in
mTeSR1 (STEMCELL Technologies, Vancouver, Canada) on
matrigel (Corning Life Sciences, Tewksbury, MA) as previ-
ously described (Easley et al., 2010). Direct differentiation
into spermatogenic lineages was performed as described
(Easley et al., 2012) but with the following modification:
human recombinant basic fibroblast growth factor (hbFGF) and
glial-derived neurotrophic factor (GDNF) were from Peprotech
(Rocky Hill, NJ). The same concentrations (1 ng/ml bFGF and
20 ng/ml GDNF) were used as previously described (Easley
et al., 2012).
Cell viability and apoptosis assays
Global cell viability was assessed by the Cell Toxicity Assay Kit
(Abcam, Cambridge, MA) as per manufacturer's instructions.
This kit is a modified MTT assay. Absorbance values for
calculating viability were determined using an Epoch Plate
Reader (BioTek, Winooski, VT). % viability for each treatment
was normalized to controls as per manufacturer's instructions.
Values shown represent average values from 3 separate trials.
Statistical significance was evaluated using paired Student's
t test, p b 0.01. Apoptosis and caspase activation assays were
conducted using a flow cytometry-based approach. The Muse®
Annexin V and Dead Cell Assay Kit and the Muse® Caspase 3/7
Assay Kit (both kits EMD Millipore, Billerica, MA) were used
as per manufacturer's instructions to prepare samples for
flow cytometry. Samples were run on the Muse® benchtop
flow cytometer (EMD Millipore, Billerica, MA). For each flow
cytometry-based experiment, 10,000 events were analyzed.
High content imaging and analyses
High content imaging of differentiated human embryonic
stem cells was performed on the ThermoFisher Cellomics
ArrayScan® VTI (Thermofisher, Waltham, MA). Quantitative
analyses for average PLZF+ colony size and average intensity of
PLZF staining per colony were determined using HCS Studio™
2.0 Cell Analysis Software included with the ArrayScan® suite.
One thousand events were analyzed per treatment condition
(n = 1000). Statistical significance was evaluated using paired
Student's t test, p b 0.01.
Cell cycle and ROS assays
Cell cycle assays were performed to examine the percentage
of haploid cells in differentiating spermatogenic cultures. Cell
cycle analyses were conducted using the Muse® Cell Cycle
Assay Kit (EMD Millipore, Billerica, MA) as per manufacturer's
instructions. Ten thousand events were analyzed for each
treatment and the percentage of haploid cells calculated.
Samples were run on the Muse® benchtop flow cytometer
(EMD Millipore, Billerica, MA). Measurements of ROS were
also conducted using a flow cytometry-based approach. ROSgeneration was assessed using the Muse® Oxidative Stress Kit
(EMD Millipore, Billerica, MA) as per manufacturer's instruc-
tions. This kit determines the percentage of cells that are
negative for ROS (healthy cells) and positive for ROS (cells
exhibiting ROS). Ten thousand events were analyzed for each
treatment, and samples were run on the Muse® benchtop
flow cytometer (EMD Millipore, Billerica, MA). % ROS+ was
averaged from three separate experiments. Statistical signif-
icance was evaluated using paired Student's t test, p b 0.01.
Reagents
Other reagents used that are not listed above include the
following: 2-bromopropane (2-BP), 1,2-dibromo-3-chloropropane
(DBCP), and l-sulforaphane (all from Sigma-Aldrich, St. Louis,
MO); PLZF antibody (R&D Systems, Minneapolis, MN); and HILI
antibody (Bioss, Inc., Woburn, MA). Secondary antibodies for
immunostaining were from LifeTechnologies (Carlsbad, CA).
Hoechst for DNA staining was from Cell Signaling Technologies
(Danvers, MA).
Results
2-BP and DBCP induce germ cell death in a human in
vitro spermatogenic model
In the quest to satisfy the 1996 US Food Quality Protection
Act ordering the implementation of a reproductive toxicant
screening program, several models have been proposed
(for review, Campion et al., 2012). However, some of the
proposed models have failed to recapitulate human repro-
ductive toxicity as chemicals that normally induce germ cell
death in humans failed to cause death in animal models (for
review, Campion et al., 2012). Furthermore, whole testes
analyses complicate sub-cellular examinations of defects
caused by reproductive toxicants directly on spermatogenic
cells. We recently developed an in vitro differentiation
model using human ESCs and iPSCs that mimics many critical
aspects of human spermatogenesis (Easley et al., 2012).
Specifically, we have previously shown that human pluripo-
tent stem cells can be differentiated in vitro into adult-type
stem and progenitor spermatonia. Second, differentiating
stem cells give rise to cells that are phenotypically similar to
pre-meiotic primary spermatocytes, post-meiotic secondary
spermatocytes, and round spermatids (Easley et al., 2012).
Because this in vitro spermatogenic model more closely
followed human spermatogenesis than rodent animal models,
we sought to determine whether this model could be utilized
for evaluate reproductive toxicity of various chemicals and
examine underlying mechanisms of toxicity. As such, we first
examined whether acute exposure to two known reproductive
toxicants, 2-BP and DBCP, induces cell death. From clinical
studies, 2-BP and DBCP have been shown to negatively affect
human spermatogenesis by directly affecting germ cell via-
bility rather than disrupt endocrine signaling from the tes-
ticular support cells (Amann and Berndtson, 1986; Bjorge
et al., 1995; Holme et al., 1991; Potashnik and Porath, 1995;
Slutsky et al., 1999; Whorton et al., 1979; Ichihara et al.,
1999; Kim et al., 1996, 1999; Son et al., 1999; Wu et al., 1999;
Yu et al., 1997). Human male embryonic stem cells (hESCs)
were differentiated as described (Easley et al., 2012) for
350 C.A. Easley IV et al.10 days into advanced spermatogenic cells. This differenti-
ation protocol reliably yields spermatogonial stem cells/
spermatogonia, primary spermatocytes, post-meiotic sec-
ondary spermatocytes, and haploid spermatids. After 10 days
differentiation, mixed germ cell cultures were treated 24 h
with either a low dose (10 μM) or high-dose (100 μM)
concentration of 2-BP or DBCP as indicated (Fig. 1). Higher
concentrations of 2-BP or DBCP overnight significantly
reduced cell viability, as assessed by a modified MTT assay
(Cell Toxicity Assay Kit, Abcam) by approximately 30%
(Fig. 1).
Because acute high exposure is known to cause infertility in
workers exposed to either 2-BP or DBCP, we next examined
whether acute, high-dose exposure induced apoptosis in
germ cells derived from hESCs in vitro. Using Annexin V flow
cytometry analyses, we observed a significant increase in
early apoptotic cells and a significant decrease in viable cells
with 24 h treatment with either 2-BP or DBCP (Fig. 2). Cell
death from necrosis in our in vitro spermatogenic cultures was
minimal as increased necrotic cell percentages in cultures
treated with 2-BP or DBCP were not significant (Fig. 2D).
One hallmark of apoptosis is the activation of cell death
machinery caspases (caspase-3, -7), which are activated in
response to both intrinsic and extrinsic cues (for review,
Lamkanfi and Kanneganti, 2010). By flow cytometry, we
examined caspase-3, -7 activation in our in vitro spermato-
genic cultures. Both 2-BP and DBCP treatment elevated the
percentage of early apoptotic cells, late apoptotic cells, and
dead cells compared to vehicle control treated spermato-
genic cells (Supplemental Fig. 1). The percentage of total
apoptotic and dead cells with 2-BP or DBCP was approxi-
mately 49% and 42%, respectively, compared to control at
approximately 26% (Supplemental Fig. 1). Taken together
with the MTT assay results and Annexin V results, these data
suggest that 2-BP and DBCP induce in vitro germ cell death
via apoptosis during acute high-dose exposures.2-BP and DBCP affect viability of distinct populations
of spermatogenic cells
Once we observed that either 2-BP or DBCP induced germ
cell death, we next sought to examine whether each
toxicant affects a specific spermatogenic lineage. Results
from epidemiological/clinical studies suggest that 2-BP
and DBCP affect different spermatogenic cell lineages.
Specifically, 2-BP depletes primary, pre-meiotic spermato-
cytes (Ichihara et al., 1999; Kim et al., 1996, 1999; Son et al.,
1999; Wu et al., 1999; Yu et al., 1997), whereas DBCP appears
to target spermatogonial stem cells/spermatogonia(Amann
and Berndtson, 1986; Bjorge et al., 1995; Holme et al., 1991;
Potashnik and Porath, 1995; Slutsky et al., 1999; Whorton
et al., 1979). To examine whether we observed a similar
cell lineage-specific effect, we differentiated hESCs into
spermatogenic lineages for 10 days, treated for 24 h with
100 μM 2-BP or DBCP, and then analyzed for expression of
the spermatogonial stem cell/spermatogonia maker PLZF
(Fig. 3A and B) and the primary, pre-meiotic spermatocyte
marker HILI (Fig. 3C). Using high content imaging, treat-
ment with either 2-BP or DBCP reduced the number of PLZF+
colonies in differentiated hESCs (Fig. 3A, left panel and 3B,
first row). Area measurements of PLZF+ colonies revealedthat DBCP significantly reduced the area of PLZF+ colonies
compared to vehicle control. 2-BP reduced colony area, but
this reduction was not statistically significant (Fig. 3A, left
panel). The overall intensity of PLZF staining, representing
expression levels of PLZF, was significantly reduced by both
DBCP and 2-BP (Fig. 3A, right panel). Closer examination of
individual colonies showed a reduction in PLZF+ cells with
both DBCP and 2-BP treatment (Fig. 3B, second row). In
examination of HILI+ colonies and cells, DBCP showed no
apparent reduction in HILI+ colonies compared to vehicle
control treated cells, whereas, 2-BP reduced the number of
HILI+ colonies, suggesting that 2-BP reduces the overall
number of spermatocytes in culture (Fig. 3C, first row).
Single colony examination showed no loss of HILI+ cells with
DBCP treatment, but 2-BP treatment reduced the number of
HILI+ cells (Fig. 3C, second row). These results suggest that
DBCP and 2-BP affect viability of distinct populations of
spermatogenic cells. Moreover, these results mimic pheno-
typic effects on spermatogenesis observed in human exposure
cases.
2-BP or DBCP treatment depletes haploid spermatids
in in vitro spermatogenic cultures
In addition to observing germ cell death of spermatogonial
stem cells/spermatogonia and primary spermatocytes, we
next sought to examine whether acute treatment with
either 2-BP or DBCP affected viability of haploid spermatids. In
our differentiation protocol, we typically observed 5–6%
haploid cell production with greater than 90% of these haploid
spermatids representing round spermatids (Easley et al.,
2012). As above, we differentiated hESCs into spermatogenic
lineages for 10 days and then treated 24 h with either 100 μM
2-BP or DBCP. Acute treatment with either 2-BP or DBCP
reduced the percentage of haploid cells (Fig. 4). Because the
treatment was 24 h, we conclude that the loss of haploid
spermatids is most likely due to cell death and not necessarily
a disruption in meiosis.
2-BP and DBCP elevate reactive oxygen species
levels to induce cell death
In our system, we demonstrated that both 2-BP and DBCP
induce germ cell death and target certain populations of
spermatogenic cells. Previous reports have indicated that the
mammalian testis is particularly sensitive to the deleterious
effects of ROS (Agarwal et al., 2014), so we next examined
whether 2-BP or DBCP generated ROS as a potential mecha-
nism in causing germ cell death. Using a flow cytometry-based
approach, we analyzed ROS (+) and (−) cells by examining
dihydroethidium (DHE) 24 h after treatment with either
100 μM 2-BP or DBCP in spermatogenic cultures derived by
differentiating hESCs for 10 days as described above. Both
2-BP (Fig. 5C) and DBCP (Fig. 5B) increased the number of ROS
(+) cells, as indicated by elevated levels of DHE, in culture
compared to vehicle control (Fig. 5A and Supplemental Fig. 2).
Additionally, both 2-BP and DBCP treatment shifted the
principal cell peak toward the ROS (+) population compared
to vehicle control (Fig. 5D). These results suggest that both
2-BP and DBCP elevate ROS in spermatogenic cells derived
from hESCs. To further confirm that both 2-BP and DBCP
Figure 1 Known reproductive toxicants decrease total germ cell viability in hESCs differentiated into spermatogenic cells.
Graphical representation showing that increasing concentrations of 2-BP and DBCP induce germ cell death in hESCs differentiated in
in vitro spermatogenic conditions. Acute treatment with each reproductive toxicant was for 24 h. Data shown represent average
values ± standard deviation from 3 separate experiments. *p b 0.01 statistical significance for 2-BP. #p b 0.01 for DBCP. % Viability
was determined by normalizing values for 2-BP and DBCP to control values from modified MTT Assays.
351In vitro model of male reproductive toxicityelevated ROS and induced oxidative stress, we performed
Live-cell 2′,7′-dichlorodihydrofluorescein diacetate (DCF)
imaging of cells 15 minutes after treatment with either 100 μM
2-BP or 100 μM DBCP. DCF fluorescence was observed in cellsFigure 2 Annexin V analyses demonstrate that 2-BP and DBCP ind
cytometry analyses indicating percent viable cells, percent early ap
cells. Samples from three experiments for each condition were poo
cells, (B) DBCP-treated cells, and (C) 2-BP-treated cells. Scatter plot
viable cells, lower right quadrant represents early apoptotic cel
(D) Graphical summary of data collected in stacked graphs showi
statistical significance for decreased % of viable cells in DBCP and 2-
of early apoptotic cells in DBCP and 2-BP treatments.treated with either 2-BP or DBCP in comparable levels to
hydrogen peroxide (H2O2) treatment (Supplemental Fig. 3A).
In response to oxidative stress, cells activate the NRF2 anti-
oxidant response pathway in which NRF2 is released fromuce apoptosis in spermatogenic cells derived from hESCs. Flow
optotic cells, percent late apoptotic cells, and percent necrotic
led and then 10,000 events were analyzed. (A) Vehicle control
s for cell populations are shown. Lower left quadrant represents
ls, upper right is late apoptotic, and upper left is necrotic.
ng average percentages of cells in each population. *p b 0.01
BP treatments. ^p b 0.01 statistical significance for increased %
Figure 3 DBCP and 2-BP reduce PLZF+ spermatogonia and HILI+ spermatocytes, respectively, in in vitro spermatogenic cultures.
(A) Graphical representation showing that 100 μM DBCP and 2-BP reduce overall colony size (left graph) and PLZF expression intensity
(right graph) compared to controls. DBCP significantly reduces mean colony size area, whereas 2-BP and DBCP significantly reduce
PLZF staining intensity. p b 0.01. (B) Representative 5X images obtained by the Cellomics ArrayScan VT1 of PLZF+ colonies used for
analyses in (A). All images are taken under the same imaging conditions and parameters. Scale bar, 5000 μm. Second row depicts
zoomed up images of representative individual colonies. Scale bar, 100 μm. (C) 2-BP reduces the number of HILI+ cells in culture.
Representative images of HILI staining (red). Scale bar, 5000 μm. Second row shows zoomed representative images of individual
colonies. Scale bar, 100 μm. Secondary-only control image is shown in Supplemental Fig. 2.
352 C.A. Easley IV et al.oxidized KEAP1 and translocates to the nucleus to activate
gene expression of antioxidants and detoxifying enzymes (Baird
and Dinkova-Kostova, 2011). Both 2-BP and DBCP treatment
caused a translocation of NRF2 into the nucleus (Supplemental
Fig. 3B), further indicating that both toxicants induce oxidative
stress.
To further implicate oxidative stress as a mechanism for
2-BP- or DBCP-mediated germ cell death, we examined
whether treatment with an antioxidant, l-sulforaphane, could
mitigate the effects of 2-BP or DBCP. After 10 days post
differentiation, germ cell cultures were treated overnight
with vehicle control, 0.5 μM, 1.0 μM, or 2 μM l-sulforaphane
prior to exposure to either 2-BP or DBCP. After pre-treatmentwith l-sulforaphane, germ cell cultures were re-fed with
fresh differentiation medium containing vehicle control,
100 μM 2-BP, or 100 μM DBCP for 24 h. Germ cell cultures
were then analyzed for viability using Annexin V flow
cytometry-based analyses. Pre-treatment with l-sulforaph-
ane attenuated the reproductive toxicant-induced cell
death and increased viability compared to cells not
pre-treated with l-sulforaphane (Fig. 6). We did observe
differential effects of l-sulforaphane pre-treatment as
1.0 μM significantly improved viability in 2-BP-treated cul-
tures, whereas 0.5 μM pre-treatment was sufficient to signif-
icantly rescue viability in DBCP-treated cultures (Fig. 6) These
results taken together with the ROS generation data indicate
Figure 4 Acute treatment with reproductive toxicants 2-BP and DBCP reduce the number of haploid spermatids in culture following
hESC in vitro spermatogenic differentiation. Flow cytometry analyses of cell cycle profiles following acute 24 h treatment with
vehicle control (A), 100 μM DBCP (B), or 100 μM 2-BP (C). Ten thousand events for each condition were examined. Representative
profiles shown. R4, R5, and R6 populations on flow cytometry analyses correspond to G0/G1, S, and G2 phases respectively. (D) Graph
of average percent haploid cell population (R3 population from plots) values with standard deviation is shown. *p b 0.01 statistical
significance of decreased % haploid cells in DBCP and 2-BP treatments. Inset shows representative image of haploid sorted cells
(R3 population) from our control group stained with protamine 1, a known spermatid marker. Scale bar, 5 μm.
353In vitro model of male reproductive toxicitythat acute 2-BP or DBCP exposure results in oxidative stress
that impacts viability of germ cells derived in vitro.Discussion
Despite the fact that spermatogenesis occurs in a low oxygen
environment, there are several different mechanisms thatFigure 5 DHE labeling indicates that 2-BP or DBCP treatment i
cytometry-based analyses of DHE labeling. Ten thousand events for e
(A) Vehicle control, (B) DBCP, and (C) 2-BP. (D) Merged flow cytom
ROS+ population after 24 h treatment with 100 μM of each indicatecan cause oxidative stress (Agarwal et al., 2014; Aitken and
Roman, 2008; Maiorino and Ursini, 2002). Spermatogenic
cells are particularly sensitive to oxidative damage, and
oxidative stressors can negatively impact spermatogenesis
(Agarwal et al., 2014; Aitken and Roman, 2008; Maiorino and
Ursini, 2002). Furthermore, oxidative stress has a profound
effect on Leydig cell steroidogenesis, and defects in testos-
terone production can affect spermatogenesis (Aitken andnduces ROS production following acute 24 h treatment. Flow
ach condition were analyzed. Representative graphs are shown.
etry graphs indicate that 2-BP and DBCP peaks shift toward the
d compound.
Figure 6 l-Sulforaphane treatment rescues 2-BP- or DBCP-
mediated cell death. Graphical representation of flow cytom-
etry data from 3 separate experiments showing that overnight
treatment with l-sulforaphane blocked reproductive toxicant-
mediated cell death. Data shown represent average % viable
cells after 24 h treatment with vehicle control or 100 μM 2-BP or
DBCP as indicated. Ten thousand events were analyzed for each
condition. Indicated l-sulforaphane concentrations are shown.
*p b 0.01 statistical significance of increased viability from
0 μM l-sulforaphane pre-treatment.
354 C.A. Easley IV et al.Roman, 2008). To ensure proper propagation of the male
germline, cells in the testis display a wide range of mechanisms
to handle this oxidative stress (Agarwal et al., 2014; Aitken and
Roman, 2008; Maiorino and Ursini, 2002). Perturbations in this
system can have catastrophic effects leading to male infertil-
ity. Thus, reproductive toxicants that generate ROS are
particularly damaging to male gametogenesis.
In this work, we demonstrate that using hESCs provides a
novel in vitro spermatogenic model to assess how reproduc-
tive toxicants affect human spermatogenesis. Our results
show that 2-BP and DBCP induce germ cell death similarly to
that observed in men exposed to each toxicant. As predicted
based on previous studies, each chemical affects different
populations of germ cells, including spermatogonia (DBCP)
and primary spermatocytes (2-BP), but both specifically
affect germ cell viability. Rodent models often implicate
the somatic support cells in germ cell viability, but our
differentiation protocol lacks somatic support cells (Easley et
al., 2012), and thus we are able to observe direct effects of
each toxicant on germ cells specifically. Our results suggest
that our in vitro spermatogenic model is ideal for examining
the effects of various toxicants on male gametogenesis.
The concentrations of each toxicant used in this study
represent an accidental occupational exposure. For DBCP,
potential exposure routes include skin contact, ingestion,
and inhalation (Anon, 2011). While exposure in the US is
limited, exposure through groundwater contamination in
limited areas is possible (Anon, 2011). However, DBCP is a
listed chemical of concern at 8 hazardous waste sites (Anon,
2011), suggesting that acute occupational exposure is still
possible. Workers exposed to DBCP can potentially inhale up
to 97 μg per day and can potentially be exposed to 5 to
125,000 times that amount through contaminated soil via
dermal contact (Anon, 2011). Despite the fact that the risk
of exposure to the general population is low, understandingthe mechanism by which DBCP affects human spermatogen-
esis is still critical for individuals living near contaminated
groundwater sites or working at DBCP-risk hazardous waste
sites.
Likewise, the dose of 2-BP utilized in this study reflects
acute accidental exposure akin to the Korean electronics
plant accident (Ichihara et al., 1999; Kim et al., 1996, 1999;
Son et al., 1999; Wu et al., 1999; Yu et al., 1997). Workers
were exposed to daily short-term doses up to 4,141 ppm
(Ichihara et al., 1999; Kim et al., 1996, 1999; Son et al.,
1999; Wu et al., 1999; Yu et al., 1997), which roughly
calculates to more than 100× the dose used in our study.
2-BP is still used today, and despite its recent classification
by the NTP as a toxicant that negatively impacts gameto-
genesis, so exposure is possible. Understanding the mecha-
nisms by which 2-BP impacts human spermatogenesis is
critical given the wide use of 2-BP.
The work presented here represents an acute, short-term
exposure, but our in vitro spermatogenesis model system
would permit longer-term, lower-dose studies to examine
more subtle effects of each toxicant with prolonged expo-
sures. Furthermore, our system can be utilized to examine the
effects of known and unknown reproductive toxicants on
human spermatogenic cells both in an acute, short-term
format (24 h) and in a longer-term setup (up to 10–20 days
treatment). This system could be utilized to study the effects
of known reproductive toxicants such as phthalates, dioxin,
and endosulfan as well as predicted or unknown chemicals
such as PFOS, HBCD, TDCPP, and Aroclor. Because of the rapid
differentiation protocol, and the ease of the system, we
anticipate that our model, which mimics several aspects of
human spermatogenesis, will serve as an ideal system going
forward for examining the direct effects of known and
unknown reproductive toxicants on human spermatogenic
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